Advisornet Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-36
Closed -$2.06K 2077
2024
Q3
$2.06K Hold
36
﹤0.01% 1749
2024
Q2
$1.89K Hold
36
﹤0.01% 1650
2024
Q1
$1.46K Buy
36
+15
+71% +$562 ﹤0.01% 1660
2023
Q4
$776 Buy
21
+2
+11% +$75 ﹤0.01% 1966
2023
Q3
$726 Buy
19
+3
+19% +$123 ﹤0.01% 1883
2023
Q2
$577 Buy
+16
New +$546 ﹤0.01% 2026
2023
Q1
Sell
-19
Closed -$1.08K 2438
2022
Q4
$1.08K Buy
+19
New +$973 ﹤0.01% 1812

Other funds holding HALO

Advisornet Financial's HALO Position: Q4 2024 in Review

Advisornet Financial sold out of Halozyme (HALO) in Q4 2024, closing a stake of 36 shares — an estimated $2.06K sold.

Advisornet Financial first reported a position in HALO in Q4 2022 and held it in 7 quarters. The position peaked at $2.06K in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Advisornet Financial reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Advisornet Financial sold 36 Halozyme shares in Q4 2024, an estimated $2.06K.
  • Advisornet Financial first reported a position in Halozyme in Q4 2022 and held it in 7 quarters.
  • Advisornet Financial's Halozyme position peaked at $2.06K in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Advisornet Financial's 13F filing for Q4 2024, filed 13 Jan 2025.